C2cure Inc. is a biotechnology company specializing in developing novel therapies for autoimmune diseases. Through cutting-edge research and innovative technology, C2cure aims to provide effective treatments that improve the quality of life for patients. With a focus on personalized medicine, the company is dedicated to bringing targeted therapies to the market to address unmet medical needs in the field of autoimmunity.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

9 Patents

#360 in Wilmington, DE

#477 in Delaware

#32,627 in US

Wilmington, DE, United States of America

C2cure Inc.

Forward Citations = 2,214

11 inventors:

Doron Adler (9 out of 35 patents)

Alex Zaretski (3 out of 3 patents)

Shai Finkman (2 out of 37 patents)

4. Ofer Pillar (2 out of 3 patents)

5. Frank D D'Amelio (2 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: C2cure Inc.. Retrieved from https://idiyas.com/company/c2cure

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]